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Foreword 
In the United States, about 70% of smokers want to quit and 50% make a quit attempt each year. 
Unfortunately, only a small percent are successful, due in part to the lack of easy access to tobacco 
dependence treatments that have been proven effective. In light of the societal costs of tobacco-related 
illness, government must do everything it can to encourage and enable smokers to quit.   
The tobacco use landscape in this country has changed in recent years -- people with lower income and 
education levels have a much higher probability of smoking. For instance, the smoking rate for those 
with a college degree is under 10%, but for those insured by Medicaid it is over 35%. Unfortunately, 
Medicaid coverage for tobacco cessation treatment depends on the state in which you live. While 
federal health reform guarantees nationwide coverage for pregnant women, it does not for all other 
Medicaid beneficiaries. Some states have made this a public health priority, but others have not.  
This policy report, based on a study by George Washington University, demonstrates that 
implementation of a comprehensive tobacco cessation program can saves lives and money. At a time 
when state and federal budgets are stretched to the breaking point, this report identifies a proven cost 
saving strategy for policy makers. 
It is imperative that states redouble their efforts to establish comprehensive coverage for tobacco 
treatment for all people insured by Medicaid. Tobacco control advocacy organizations must fully 
support this campaign and include it in their 2012 plans of action. Giving all Americans unfettered 
access to cessation services will help millions of smokers quit, saving human life and financial 
expenditure.  
 
Jud Richland, President 
Partnership for Prevention   
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Executive Summary 
A new research study from the George Washington University demonstrates that including a 
comprehensive smoking cessation benefit as part of insurance coverage under Medicaid can: 
1. Help people stop smoking, 
2. Lower the risk of heart-related illnesses that lead to hospitalization, and 
3. Save money by reducing the number of costly hospitalizations. 
The George Washington University research report concluded that every $1 invested in the 
Massachusetts Medicaid Tobacco Cessation Program led to average savings of $3.12 in cardiovascular
-related hospitalization expenditures. Thus, a net return on investment of $2.12 was realized for every 
dollar invested. On average, these savings were recouped within slightly more than a year after the 
benefits were used. 
Most states currently offer some coverage for tobacco cessation under Medicaid, but few offer a 
comprehensive benefit. Advocates in many states are actively working to increase Medicaid tobacco 
treatment coverage and the new study and this policy paper will be excellent new tools to strengthen 
their campaigns. 
In summary, this new research shows that linking public health efforts to decrease smoking with 
insurance coverage for counseling and cessation medications can be an effective strategy to improve 
population health and lower health care costs. 
The new George Washington University study is available at: 
http://dx.plos.org/10.1371/journal.pone.0029665 
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Introduction 
Smoking is the number one preventable cause of death and disease in the United States.  About 
440,000 people die from causes attributed to smoking each year.  For each death, an additional 20 
people suffer from a smoking-related disease, including heart attacks, coronary heart disease, lung 
cancer, emphysema and chronic obstructive pulmonary disease.1   While about one out of every five 
Americans smokes, the rate among low-income adults insured by the Medicaid program is almost 
twice as high.2  The costs of treating tobacco-related illnesses in Medicaid were estimated to be about 
11 percent of the total program cost, or $22 billion, in 2004.3  Today, 11 percent of total Medicaid 
costs would be twice as high, almost $50 billion per year. 
Because of the stark toll of smoking and the prevalence of smoking among low-income Medicaid 
beneficiaries, strategies to reduce smoking among this population rank high on the public health 
agenda for the nation.  One of the Healthy People 2020 public health objectives for the U.S. is to 
“increase comprehensive Medicaid insurance coverage of evidence-based treatment for nicotine 
dependency in States and the District of Columbia.”4  The new findings discussed in this report show 
that smoking cessation should not only be part of our public health objectives, but also a critical 
element of the national agenda to lower the costs of medical care.   
After an extensive review of the research evidence, the U.S. Public Health Service has recommended 
using a variety of clinical treatment options, including counseling and medications, to promote 
smoking cessation:5 
Nicotine replacement therapy, including gum, patch, nasal spray, inhaler and lozenge 
Varenicline (Chantix) 
Bupropion (e.g., Zyban and generic equivalents) 
Group, individual, and telephone counseling 
Comprehensive tobacco cessation coverage consists of all seven first-line medications and all three 
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recommended counseling strategies. This flexible coverage will permit smokers to choose the 
type of treatment that is appropriate for them. The recommendations note that medications and 
counseling are both effective themselves, but that combined use may be the most effective.   
The National Commission on Prevention Priorities, convened by Partnership for Prevention, 
ranks clinical preventive services based on their health impact and cost effectiveness. It is 
noteworthy that the Commission assigned tobacco cessation treatment a place at the top of its 
list of clinical services in these two categories. The ranking of clinical preventive services is 
available at: 
http://www.prevent.org/data/files/initiatives/
prioritiesamongeffectiveclinicalpreventivesvcsresultsofreviewandanalysis.pdf 
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Medicaid and Tobacco Cessation 
Medicaid is a joint federal-state program that provides health insurance coverage to low-income people 
in the United States, including children, adults, seniors and people with disabilities.  About 57 million 
people will participate in Medicaid during an average month in 2012, making it the largest insurance 
program in the nation.  The Patient Protection and Affordable Care Act (ACA) requires a large 
expansion of Medicaid eligibility for adults with incomes under 133 percent of the federal poverty line 
beginning in 2014. The Congressional Budget Office expects enrollment to exceed 70 million by later 
in the decade.6   
Medicaid beneficiaries may receive smoking cessation medications and counseling, although the 
specific benefits and policies are determined by state Medicaid programs.  Federal law (Title XIX of 
the Social Security Act) establishes the basic framework for this entitlement program, but places many 
of the key operational requirements and decisions in the hands of states. This includes many aspects of 
eligibility for Medicaid coverage, the health benefits that are covered, and how much to pay for health 
care services.  The federal government pays for the majority of Medicaid costs, on a matching basis 
with states.  The level of federal matching generally depends on the per capita income in states: states 
with lower incomes receive a higher federal matching rate than states with higher per capita incomes.  
Federal policy changed with the passage of the ACA in early 2010.  Effective October 2010, all state 
Medicaid programs are required to offer comprehensive cessation benefits for pregnant women, 
including medications recognized as effective, diagnostic and counseling services. These services must 
be available without copayments.7  Moreover, beginning in 2014, state Medicaid programs may no 
longer exclude tobacco cessation medications from coverage.8   
Newly eligible adults (those with incomes up to 133 percent of poverty who are not eligible under 
current Medicaid rules) must at least receive “essential health benefits” established under the ACA for 
those covered by private health insurance.  The ACA also requires coverage of all preventive services 
rated by the U.S. Preventive Services Task Force with an “A” or “B” recommendation without cost-
sharing, and tobacco cessation services are included in that list.  As noted earlier, it is expected that 
these expansions will increase the number of adults covered by Medicaid by more than 10 million.   
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For those already eligible for Medicaid, as indicated above, most states already cover at least 
some smoking cessation services. But the ACA offers higher federal matching rates to states 
that cover all Preventive Health Services Task Force-recommended services without cost-
sharing.   
The ACA has already led to expansions of smoking cessation coverage for pregnant women and 
further expansions of coverage will be required beginning in 2014.  The Centers for Medicare 
& Medicaid Services (CMS) has encouraged states to adopt more comprehensive tobacco 
cessation policies consistent with those recommended by the U.S. Public Health Service. The 
CMS noted that federal matching funds are available to help states pay for the cessation 
services including medications, in-person counseling and telephone quitlines.9  CMS also 
encouraged states to minimize barriers to use of these services by eliminating or minimizing 
copayments and to actively promote the availability of these services both to patients and 
providers.   
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New Research 
In July 2006, the state of Massachusetts initiated a comprehensive smoking cessation policy under its 
Medicaid program (called MassHealth).  Based on prior research about effective smoking cessation 
interventions, the state passed legislation requiring a program that included both tobacco cessation 
medications, including all treatments that are approved by the Food and Drug Administration, as well 
as counseling services.10   
Medicaid enrollees can obtain up to two 90-day regimens of smoking cessation medications per year, 
although higher levels could be permitted with preauthorization.  The medications are available if 
prescribed by a Medicaid provider (doctor, nurse practitioner or physician assistant).  Copayments are 
nominal ($1 to $3).  Medications available include: 
Nicotine replacement therapy medications, including gum, patch or lozenge.  With 
preauthorization, the nasal spray or inhaler can be authorized. 
Varenicline (Chantix) or bupropion (the generic form of Zyban).   
Counseling is available, with up to 16 sessions per year, including two intake/assessment sessions and 
14 counseling sessions (with more available with preauthorization), in the form of individual or group 
sessions.  Since in-person counseling is not available statewide, participants can also use telephone 
counseling services, including Quitworks, a program offered by the Massachusetts Department of 
Public Health.  These services are also available from all Medicaid managed care plans and some plans 
offer additional benefits.   
Three studies of the Massachusetts program have been published.  The first two were conducted by Dr. 
Thomas Land and his associates, primarily from the Massachusetts Department of Public Health.  The 
third study was an independent cost-benefit study, conducted by researchers from George Washington 
University.  (To provide the broad access to this research, all three studies were published in open-
access journals that can be read and downloaded without charge.)   
 
Massachusetts’ Comprehensive Tobacco Cessation Program 
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1.   Use of the program and the effect on smoking rates (Land, et al. 2010a).11  This study found 
that, in part because of broad publicity and outreach for the cessation program, the program 
achieved a high utilization rate, reaching about 37 percent of Medicaid smokers.  Based on 
analyses of time trends from CDC’s Behavioral Risk Factor Surveillance System (BRFSS) 
survey, the rate of smoking among Medicaid beneficiaries fell from about 38 percent to 
about 28 percent in two and a half years, a statistically significant reduction.  Available at 
http://www.plosone.org/article/info:doi%2F10.1371%2Fjournal.pone.0009770. 
2.  The effect of the program on hospitalization rates for program participants (Land, et al. 
2010b).12  This study investigated changes in inpatient hospitalization trends for those who 
used the cessation benefit, before and after they started using the tobacco medications.  
Based on an analysis of changes in hospitalization trends, the researchers found that 
admissions for heart attacks (acute myocardial infarction) fell by 46 percent and admissions 
for coronary heart disease fell by 49 percent.  Admissions for non-specific chest pain fell by 
32 percent, although these findings were marginally significant statistically.  Admission 
rates for other causes, including respiratory disease, did not change significantly. Available 
at:     http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%
2Fjournal.pmed.1000375   
3.  The return on investment (the costs and benefits) of the program (Richard, et al. 2012).13  
The George Washington University study, available at http://dx.plos.org/10.1371/
journal.pone.0029665, measured the cost of the tobacco cessation program (medications, 
counseling and outreach) from administrative data and estimated the savings from reducing 
cardiovascular hospital admissions, based on analyses of the Medical Expenditure Panel 
Survey and the Behavioral Risk Factor Surveillance System, as well as the hospitalization 
study by Land, et al.  All told, the study found the annual cost of the tobacco cessation 
benefit was $183 per user, but the averted annual hospital savings averaged $571 per 
participant (all in 2010 dollars).  Every $1 invested in program costs led to average savings 
of $3.12 in cardiovascular-related hospitalization expenditures, so there was a net return on 
investment of $2.12 for every dollar invested.   On average these savings were recouped 
within slightly more than a year after the benefits were used.  These are conservative short-
term estimates of savings, since they do not include longer-term savings, nor savings that 
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may occur outside the Medicaid program (e.g., increased worker productivity, reduced harm 
to other family members from second hand smoke, etc.).  The table below summarizes the 
average annual cost of the program per participant and the average annual savings 
attributable to reductions in three types of cardiovascular disease.  (The published article 
indicates a range of potential savings; this chart simply shows the average estimated costs 
and savings.) 
 
 
 
The combined lessons of these three studies are that:  
A comprehensive tobacco cessation program can reach a large proportion of Medicaid 
smokers and lead many of them – at least temporarily – to stop smoking. 
These smoking reductions can lead to lower rates of severe cardiovascular disease and 
lead to fewer hospital admissions for those causes. 
The program can be relatively inexpensive and can save much more than it costs; these 
savings can be quickly recouped by the Medicaid program.   
Since Medicaid is jointly funded by both states and the federal government, there would be both 
state and federal savings.  Currently, the federal Medicaid matching rate ranges from 50 percent 
for more affluent states to 74 percent for the state with the lowest per capita income, so states 
would retain about 26 to 50 percent of the savings.   
Table 1.  Summary of Average Costs and Inpatient Hospital Savings Attributable to 
Medicaid Smoking Cessation Program in Massachusetts 
(All in 2010 
Dollars) 
Program 
Costs 
(Medications, 
Counseling, 
Outreach) 
Savings from 
Fewer Heart 
Attacks 
Savings from 
Less Coronary 
Heart Disease 
Savings from 
Less Non-
specific Chest 
Pain 
Net Savings 
(Total Savings 
Minus Cost) 
Annual Cost 
per Cessation 
Benefit Par-
$183 $383 $117 $71 $388 
Rate per Dol-
lar Invested 
in Program 
$1 $2.09 $0.64 $0.39 $2.12 = net 
return on  
investment 
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Putting the Findings into Context 
Years of research about smoking and efforts to quit reveal two important lessons.  One, most smokers 
want to quit, but they often lack the tools to help them stop.  Second, it is difficult to quit; most of 
those who quit relapse later.  Tobacco dependence is a chronic disease and it may be necessary to help 
smokers to quit many times. Effective clinical treatments – using medications and/or counseling – are 
available.5 The research also reveals that even relatively brief reductions in smoking can have 
important health paybacks such as reduced hospitalizations.   
The Massachusetts studies do not reveal how many of the low-income smokers who quit remained 
tobacco-free or for how long.  It is likely that many of those who quit, conceivably even most, 
eventually begin smoking again.   Nonetheless, the annual medical savings attributable to even a brief 
reduction in smoking ($571 per program participant) outweighed the costs of the prevention program 
($183 per participant) and yielded these savings rapidly. Moreover, those who started smoking again 
later could use the smoking cessation benefits again at a later time; the program administrators realized 
how hard it is to quit permanently and that repeated efforts may be needed. 
The cost-benefit study provides conservative short-term estimates of the savings to the Medicaid 
program.  They do not include other potential savings, such as the reduced cost of purchasing 
cigarettes (typically more than $5 per pack), health improvements in other family members due to 
reduced second-hand smoke, or improved work productivity or quality of life.   
To some it may seem surprising that the savings due to smoking are related to heart health.  Smoking 
leads to coronary heart disease and heart attacks, the leading cause of death in the United States.  
Tobacco use raises the risk of coronary heart disease by two- to four-fold and may particularly increase 
the risk of heart problems for non-elderly adults.14  It raises blood pressure, reduces cardiac capacity 
and can harm blood vessels.  Other analyses have found that smoking cessation can be the most cost-
effective long-term method of reducing cardiovascular disease in the United States.15 
It is worth noting that the study by Land, et al. did not investigate the potential effects of the smoking 
cessation program on improving birth outcomes among pregnant women.  The study examined 
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hospital claims related to the program participants themselves and did not link records between 
pregnant women and their babies.  While there is a substantial body of research about the 
harmful effects of smoking by pregnant women and about smoking cessation during 
pregnancy16, this study was not designed to examine that issue. 
It should also be noted that insurance coverage alone may not guarantee utilization of cessation 
treatments or decrease of smoking prevalence. Other factors come into play, most importantly 
aggressive promotion of the benefit and the available treatment services to both members and 
providers alike. Massachusetts implemented public awareness campaigns to inform Medicaid 
beneficiaries about the covered services, urging them to use the benefit to quit smoking. And 
repetitive promotion to providers by MassHealth, the Massachusetts Tobacco Control Program, 
and many partner organizations also helped ensure the success of the program.  
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Until recently, federal policy encouraged, but did not require, state Medicaid programs to cover 
smoking cessation, including medications or counseling services.  As of November 2011, most states 
offered at least some smoking cessation services under Medicaid.17  Six states (Indiana, Massachusetts, 
Minnesota, Nevada, North Carolina and Pennsylvania) covered all the treatments recommended by the 
U.S. Public Health Service, including all five forms of nicotine replacement therapy (NRT), 
varenicline and bupropion as well as individual and group counseling.  (NRT gum, patch and lozenge 
options are generally available on an over-the-counter basis, whereas NRT inhalers and sprays and 
varenicline and bupropion must be prescribed by a physician or approved clinician.  However, in order 
for Medicaid to cover the costs of the over-the-counter NRT treatments, they must generally be 
prescribed by a physician or other approved clinician.)   
Most of the rest of the states offered at least some of these services, although sometimes the benefits 
varied across Medicaid managed care plans or for different populations (e.g., pregnant women). The 
Appendix summarizes data about the level of smoking among low-income adults in each state in 2009-
10 and the Medicaid smoking cessation coverage available as of November 2011.  While all states 
could gain by reducing the level of smoking, the greatest gains can be realized in states with the 
highest smoking prevalence rates.  It is particularly noteworthy that some of the states with the highest 
rates of smoking have less coverage; these include Georgia, Kentucky, Tennessee and West Virginia.   
States do not need to wait to further expand Medicaid smoking cessation coverage options – they may 
adopt them at any time. However, a major barrier now facing many state Medicaid programs is state 
budget shortfalls. Most states are still recovering from the worst recession in recent decades, which led 
almost all states to take steps to contain Medicaid costs, such as reducing payment rates to providers or 
restricting the scope of benefits.18  Budget concerns can make states reluctant to expand the scope of 
Medicaid benefits, no matter how worthy.   
The budgetary significance of the findings from the Massachusetts studies is that comprehensive 
tobacco cessation programs can begin to recoup savings rapidly since hospitalization rates fall quickly. 
States Can Expand Cessation Coverage Now 
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The latest study indicates that most of the estimated savings may be recovered within a little 
more than a year. When budgets are tight, policy officials care most about policies that will 
save money in the following year or two.  The Massachusetts results meet that test.  Creating 
comprehensive tobacco cessation coverage policies in Medicaid can both improve public health 
and lower medical costs.  
Because the prevalence of smoking is so high among the low-income Medicaid population, 
state officials should take steps to make comprehensive smoking cessation benefits available. 
This should include the full array of Food and Drug Administration approved medications and 
the counseling therapies recommended by the U.S. Public Health Service.  The findings from 
the studies suggest that greater use of smoking cessation benefits leads to larger reductions in 
smoking rates, which in turn leads to lower rates of heart disease and to greater medical 
savings.    
 
 12 
Planning for Better Health 
Improving smoking cessation efforts in Medicaid involves at least two, and preferably three, phases.   
Planning.  The first step includes motivating the Medicaid agency or state legislature to 
expand smoking cessation coverage.  Soon after, decisions must be made about what services or 
treatments to cover and how they will be delivered.  The key governmental agencies to involve are the 
state Medicaid agency and the state public health agency; they are often separate agencies.  Non-
governmental organizations and individuals that can contribute to the planning may include:  
state affiliates of organizations like the American Heart Association, American Lung 
Association, American Cancer Society, or the American Public Health Association; 
health care organizations, such as state medical or nursing associations, community health 
centers, or hospitals; 
Medicaid managed care organizations;  
community organizations, including civil rights, health, religious or low-income advocacy 
organizations who want to promote public health; and 
respected public health experts. 
Many organizations have created a variety of useful guidelines and recommendations in this area.  
Some resources include: 
U.S. Public Health Service.  Treating Tobacco Use and Dependence: 2008 Update.            
http://www.ahrq.gov/clinic/tobacco/tobaqrg.pdf 
American Lung Association. Helping Smokers Quit.  Tobacco Cessation Coverage 2011. 
 http://www.lungusa.org/assets/documents/publications/smoking-cessation/helping-smokers-
 quit-2011.pdf. 
American Lung Association and Partnership for Prevention.  Save Lives and Money.  Help 
People on Medicaid Quit Tobacco.  2010.                                                                             
http://actiontoquit.org/uploads/documents/Save_Lives_and_Money_Medicaid_2010.pdf  
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Partnership for Prevention. Increasing Access to Tobacco Cessation in States: Action to 
Quit Case.  Studies.  May 2011.                                                                                  
http://actiontoquit.org/uploads/documents/A2QCase%20StudiesGuide_FINAL_6-2-
11.pdf 
Partnership for Prevention. Colorado Tobacco Cessation and Sustainability Partnership, 
a Case Study.  May 2011. 
http://actiontoquit.org/uploads/documents/Colorado%20Tobacco%20Cessation%
20and%20Sustainability%20Partnership%20Case%20Study%205-6-11.pdf 
Implementation.  The continued involvement of organizations during the implementation 
phase is ultimately critical.  Efforts to bolster smoking cessation will not work if smokers and 
their families and the health care provider community are not aware of the smoking cessation 
benefits available and how to use them. Insurance coverage alone will not guarantee utilization 
of tobacco cessation services – there must be accompanying communication efforts to promote 
them. The Medicaid and public health agencies can work together to develop educational 
materials and outreach plans that are appropriate for:  
Medicaid enrollees and their families;  
Clinicians who must prescribe the services, particularly community health centers and 
primary care physicians, nurse practitioners and physician assistants; 
Pharmacists and counselors who must provide the medications and counseling; and 
Managed care plans and pharmacy benefit administrators that will often administer the 
benefits. 
Many of the materials that were developed in Massachusetts can be found at:                      
http://quitworks.makesmokinghistory.org/tools-resources/masshealth.html. 
Evaluation.  Evaluation of the new coverage initiatives can help indicate whether they were 
successful and identify barriers that may have kept them from being as effective as they might 
have been.  The studies reviewed in this analysis reveal the results from one state, but others 
may want to conduct evaluations of other states’ initiatives.  State public health departments, 
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universities or other research organizations may be able to help conduct evaluation analyses.  
Some of the critical questions are: 
Are Medicaid enrollees (or their families) and primary care clinicians aware of their 
tobacco cessation coverage?  Do they understand how to use the benefits? 
How many Medicaid beneficiaries use the smoking cessation benefits and which kinds 
of benefits did they use?  What types of people use the benefits?  For example, how 
many are pregnant women, what are their ages and educational levels, and are they 
clustered in certain geographic areas? 
Are there changes in the rate of smoking among Medicaid beneficiaries or among those 
who use the benefits?  How long do people remain tobacco-free? 
Are there changes in the use of medical services, such as hospitalization rates, 
emergency department use?  Is there evidence of other health changes, such as better 
birth outcomes? 
What are the costs of the program and the savings attributable to it? 
In an era in which policymakers are seeking proven interventions to improve heath and reduce 
spending, the Massachusetts Medicaid experience is both instructive and inspirational.  
 15 
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